TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 5.85nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 4.48nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 25.2nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 23.2nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 11.7nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 25.9nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 17.6nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 5.27nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 56.8nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 49.7nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 112nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 111nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 111nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 58.1nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 34.1nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 34.2nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 49.6nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 34.3nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 26.6nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 3.96nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 25.6nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 11.8nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 7.97nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 12.3nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 5.64nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 30.2nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 190nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 135nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 240nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 106nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 141nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 261nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 11nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 7.24nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 24.3nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 23.2nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 14.4nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 32.5nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 34.9nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 134nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 26.1nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 29nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 42.8nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 25nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 31.8nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 3.13nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 23.9nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 13.7nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 46.6nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Homo sapiens)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 43nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair